A hand-held device to detect antibiotic resistant bacteria? Some researchers in Singapore made this idea a reality.
µMap ID – a new technique for identifying the targets of drug candidates
Finding the target of drug candidates is often challenging. A new technique called µMap ID may speed up this process.
Chemistry & COVID-19
The COVID-19 pandemic is consuming our news feed at the moment – while you’re self-isolating read about some of the great science research going on to combat our newest virus.
Putting chemists out of business- the immunotherapy revolution
The development of chemotherapy revolutionised the treatment of cancer in the 20th century, however, side effects have remained problematic. Immunotherapy, using the body’s natural immune system to fight cancer, may be a safer and more effective alternative.
How a Small, Organic Molecule Reigns in the Immune System
A Chinese research group has employed a chemical proteomic strategy to determine the mechanism of action of the anti-inflammatory molecule itaconate. Itaconate non-enzymatically modifies cellular proteins in order to modulate their activity, leading to a reduction in the activation of immune cells, which could pave the way to an autoimmune therapy.
Development of new tools for single RNA imaging
Detection of movement of single RNA within live cell was achieved using Quantum Dot Nanobeacons.
Now slide real smooth: Using peptide coatings to prevent biofilm formation
When it comes to milk, preventing bacterial contamination on dairy equipment is key. Researchers in Israel developed a biological coating to prevent biofilm formation and keep their moo-juice fresh and clean.
Scanning for Skin Cancer
The idea that a full body scan can give comprehensive medical prognosis may be closer than we realize. Scanning mass spectrometry has been used to differentiate between healthy and cancerous skin cells. We can literally scan a person for skin cancer!
Destroying Rogue Kinases with Degraders
Aberrant enzyme activity drives many types of cancer and other human diseases. Traditional drugs targeting such enzymes face a variety of challenges. Here, researchers use a new small molecule “degrader” to destroy an enzyme involved in cancer.